Liu Wei, Guan Wei-Jie, Zhong Nan-Shan
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou 510120, China.
Engineering (Beijing). 2020 Oct;6(10):1076-1084. doi: 10.1016/j.eng.2020.10.003. Epub 2020 Oct 15.
Coronavirus disease 2019 (COVID-19)-the third in a series of coronavirus infections-has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality. Building on its legacy of managing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), China has played a key role in the scientific community by revealing the viral transmission routes and clinical characteristics of COVID-19 and developing novel therapeutic interventions and vaccines. Despite these rapid scientific and technological advances, uncertainties remain in tracing the original sources of infection, determining the routes of transmission and pathogenesis, and addressing the lack of targeted clinical management of COVID-19. Here, we summarize the major COVID-19 research advances in China in order to provide useful information for global pandemic control.
2019冠状病毒病(COVID-19)——一系列冠状病毒感染中的第三种——已在21世纪引发了一场全球公共卫生事件,导致全球大量发病和死亡。基于其在管理严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)方面的经验,中国通过揭示COVID-19的病毒传播途径和临床特征以及开发新的治疗干预措施和疫苗,在科学界发挥了关键作用。尽管取得了这些迅速的科技进步,但在追踪感染源、确定传播途径和发病机制以及解决COVID-19缺乏针对性临床管理方面仍存在不确定性。在此,我们总结了中国在COVID-19方面的主要研究进展,以便为全球疫情防控提供有用信息。